Treatment Registry
TR-0301 ActiveRecorded September 2, 2026Last verified September 3, 2026

Brand semaglutide

Sold by GOAL.MD · Injection, pen · every brand semaglutide record

What you actually pay

Per month

$389

Medication · TrumpRx offer$294
Required membership$95

Added from the figures recorded below.

Price

TermPer monthCharged today
TrumpRx offer

Get Wegovy® (semaglutide 2.4mg) prescribed online by a US physician. Brand-name pen via TrumpRx from $294/mo. Free shipping, FSA/HSA eligible.

source, read September 2, 2026

Per month$294Charged today$294
Visit GOAL.MD

We earn nothing from this link. GOAL.MD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

  1. September 2, 2026$294
  2. September 3, 2026$294
  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
MembershipRequired. $95 per month. “Access brand-name weight loss medications through manufacturer savings programs. GOAL.MD provides physician evaluation for $95/month.”
Consult feeNone. “Free consultation · FSA/HSA eligible · No auto-billing on compounded programs”

Not yet checked: pharmacy, states and cancellation.

Recorded from goal.md. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026This is a heavily client-rendered site: most routes (pricing, terms, refund policy, dedicated FAQ, /semaglutide, /tirzepatide, /cost, /plans, /medicare-glp1-bridge) return only a generic 53-character homepage shell in this tool's output. Substantive content was only recoverable via sitemap.xml plus individual landing pages whose real content lives in the meta description (visible as page text). No terms/refund/cancellation page could be reached, so cancellation is recorded as not found even though '3-month plan' language and 'No auto-billing' appear on the semaglutide page. 'Free consultation, nationwide' falls short of an explicit 50-state claim. The $95/month 'Brand-Name GLP-1 Access' fee is a physician-evaluation membership that explicitly excludes the medication (billed separately via TrumpRx/LillyDirect) — a clean example of the membership-vs-price distinction this brief warns about.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0301
Readings
2

Related records

What else GOAL.MD sells

All GOAL.MD programs and terms

Brand semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 67 records of the same molecule.

Cite this entry

Treatment Registry. (2026). GOAL.MD brand semaglutide (TR-0301). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0301

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.